Why did a chemistry journal fix fraud with a correction instead of a retraction?

Chemical Communciations

Are some cases of research fraud fixable with a correction notice?

A chemistry journal thought so in 2014, when it issued a correction notice for a 2012 paper after the first author admitted to manipulating an image. After an investigation, the publisher agreed the manipulation was a “clear breach” of its ethical guidelines, but decided not to retract the paper since the overall conclusions remain valid.

The last author told us the first author had to repeat the experiments under supervision, and received a “serious warning.”

It’s an older notice, but one we thought interesting enough to cover now. Once you’ve read through the journal’s reasoning, tell us if you agree with the decision to correct (rather than retract) the paper in a poll at the bottom of this post.

Here’s the correction for “A novel route for preparing highly proton conductive membrane materials with metal-organic frameworks,” issued by Chemical Communications:

Continue reading Why did a chemistry journal fix fraud with a correction instead of a retraction?

Researcher denied PhD after “recklessly” committing misconduct

Molecular PharmacologyA doctoral student at the University of Houston in Texas will not receive his PhD, following an institutional investigation into his work.

Mousa Abkhezr, the researcher in question, is no longer enrolled at the University of Houston, his former supervisor told us.

In June, the probe into papers co-authored by Abkhezr resulted in the retraction of a study in the American Journal of Physiology – Renal Physiology (AJP). Now, his ex-supervisor, Stuart Dryer, has pulled two more papers co-authored by the pair in Molecular Pharmacology.

Here’s the retraction notice for “Angiotensin II and Canonical Transient Receptor Potential-6 Activation Stimulate Release of a Signal Transducer and Activator of Transcription 3–Activating Factor from Mouse Podocytes:” Continue reading Researcher denied PhD after “recklessly” committing misconduct

A researcher sued critics of his work. Now he has 13 retractions.

Fazlul Sarkar
Fazlul Sarkar

A cancer researcher who sued PubPeer commenters for criticizing his work has lost six more papers, bringing his total to 13 retractions. 

Four of the new retraction notices issued by the journal Cancer cite an investigation at Wayne State University in Michigan into the work of Fazlul Sarkar and some of his colleagues. All the new notices, including the other two in Breast Cancer Research and Treatment, are for image-related issues.

Retraction Watch readers will recognize the name Fazlul Sarkar, who took PubPeer to court to unmask the anonymous critics whose comments cost him a job at the University of Mississippi. According to this document, Sarkar retired from Wayne State this year.  

Here’s the first of the four Cancer retraction notices, all of which were issued on July 29: Continue reading A researcher sued critics of his work. Now he has 13 retractions.

Researcher whose PhD was revoked is no longer at Harvard lab

mend.2016.30.issue-8.coverA research fellow at Harvard Medical School whose PhD was revoked last month is no longer working in his former lab, Retraction Watch has learned. 

An archived version of the lab site for Alfred Goldberg from December, 2015, lists Sudarsanareddy Lokireddy as a postdoctoral fellow; however, Goldberg’s current lab site doesn’t include Lokireddy as a lab member.

We contacted Goldberg’s lab, and he was unavailable for comment. We were told all of his lab members are on the current website.

Lokireddy has also logged his sixth retraction. But this case isn’t as straightforward as it seems.

Continue reading Researcher whose PhD was revoked is no longer at Harvard lab

Four more retractions for biomaterials researcher brings total to 7

Journal of Controlled ReleaseA biomaterials researcher has lost four more papers for figure-related issues such as duplications, bringing his total to seven retractions.

We previously reported on three retractions two by the Journal of Controlled Release (JCR) of papers co-authored by Hossein Hosseinkhani, who is currently based at the National Taiwan University of Science and Technology in Taipei. Now, the JCR is pulling four more studies that list Hosseinkhani as a co-author.

Here’s the retraction notice for “Enhanced expression of plasmid dna – cationized gelatin complex by ultrasound in murine muscle:” Continue reading Four more retractions for biomaterials researcher brings total to 7

Ex-Mount Sinai postdoc who falsified 50+ images earns 5-year funding ban

ori-logoA former postdoctoral researcher at the Mount Sinai School of Medicine in New York has received a five-year funding ban after an investigation concluded that they had falsified data underlying more than 50 images.

According to a report released today by the Office of Research Integrity (ORI), Zhiyu Li falsified Continue reading Ex-Mount Sinai postdoc who falsified 50+ images earns 5-year funding ban

1st retraction for cancer researcher who doctored data in 11 studies

LeukemiaA cancer journal has retracted a paper co-authored by a researcher who falsified or fabricated data in 11 studies, according to an investigation by the Office of Research Integrity (ORI).

In December 2015, an ORI probe into the work of Girija Dasmahapatra concluded that he had

…duplicated, reused, and/or relabeled Western blot panels and mouse images and claimed they represented different controls and/or experimental results…

Dasmahapatra left the Virginia Commonwealth University (VCU) in July 2015.

Here’s the retraction notice, issued in April 2016: Continue reading 1st retraction for cancer researcher who doctored data in 11 studies

Harvard researcher’s PhD revoked, former group earns three more retractions

Journal of Biological ChemistryA research fellow at Harvard has lost his PhD from a university in Singapore after being found guilty of falsifying data, and his former group leader’s contract has been terminated by his institution.

But that’s not the whole story. This tangled mess involves not only the Harvard researcher, Sudarsanareddy Lokireddy, and his former boss, Ravi Kambadur at the Nanyang Technological University (NTU) in Singapore, but an as-yet unnamed colleague of theirs who, we’re told, has admitted making up data in three papers, on which Lokireddy and Kambadur are co-authors. Bear with us as we walk you through this tale.

Two of those papers have been retracted by The Journal of Biological Chemistry (JBC); one in Molecular Endocrinology has yet to be pulled. Kambadur, who held joint appointments at the NTU and the Agency for Science, Research and Technology (A*STAR) in Singapore, has now had his contract terminated at both institutions.  Continue reading Harvard researcher’s PhD revoked, former group earns three more retractions

Authors who lost paper linking fecal transplants to obesity have another retracted

International Journal of ObesityAn obesity journal has retracted a study by authors who previously lost another paper that suggested a link between the fecal microbiome and obesity.

We first came across on the now-retracted paper in the International Journal of Obesity (IJO) in April when we reported on the authors’ other retraction in Diabetes. The 2014 paper had a corrigendum, published the same year, and also for image-related issues. Since then, however, the journal has pulled the IJO paper and its associated corrigendum at the request of the French National Institute of Agronomic Research (INRA) in Paris. Continue reading Authors who lost paper linking fecal transplants to obesity have another retracted

PLOS ONE pulls malaria study for “inappropriate manipulation” of figures

PLOS OnePLOS ONE has retracted a malaria paper after an institutional investigation found evidence the authors had manipulated multiple figures.

According to the notice, the authors’ institution — the International Centre for Genetic Engineering and Biotechnology (ICGEB) in New Delhi, India — recommended the journal retract the paper.

Here’s the retraction notice, issued by PLOS ONE on June 30: Continue reading PLOS ONE pulls malaria study for “inappropriate manipulation” of figures